Nottingham pharma firm increases overseas revenue
Nottingham-based pharma firm XenoGesis has reported a third year of export growth with one third of its revenue now coming from overseas.
In the financial year ending March 2017, 33% of all revenue came from overseas clients with the largest increases in revenue from clients in Europe and the USA.
Richard Weaver, founder and managing director of XenoGesis, said: “This growth in exports has exceeded our expectations. It highlights the attractive proposition the UK has to offer; whether it is a lack of expertise locally in overs... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
